Abstract
Chronic hypertension (CH) during pregnancy, identified before or within the first 20 weeks, presents varying risks depending on the timing of diagnosis. This real-world study was conducted from January 2018 to June 2023 and included singleton pregnancies with CH to compare pre-pregnancy CH (Group 1) and newly diagnosed CH (Group 2). There were 565 women in the final analysis, with 307 in Group 1 with pre-pregnancy CH and 258 in Group 2 with new-onset CH. Those in Group 1 more frequently had pre-gestational diabetes and a history of hypertensive disorders in pregnancy, whereas Group 2 had a higher incidence of excessive gestational weight gain. Notably, 56.2% of Group 2 patients did not receive antihypertensive treatment before 20 weeks, while the proportion was 36.2% in Group 1, resulting in a significant difference in baseline blood pressure. The study revealed higher incidences of preterm preeclampsia (44.2% vs. 34.9%) and placental abruption (5.4% vs. 2.0%) in Group 2 compared to Group 1. After adjustment, logistic regression indicated that Group 2 had a 1.8-fold higher risk of preterm preeclampsia than Group 1. These findings suggest that pregnant women newly diagnosed with CH in the first 20 weeks face increased adverse outcomes compared to those diagnosed before pregnancy. Intense monitoring and earlier intervention may help manage women with new-onset CH.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 digital issues and online access to articles
$119.00 per year
only $9.92 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
Data availability
The data is available from the first author [QW Nie], upon reasonable request.
References
Panaitescu AM, Syngelaki A, Prodan N, Akolekar R, Nicolaides KH. Chronic hypertension and adverse pregnancy outcome: a cohort study. Ultrasound Obstet Gynecol. 2017;50:228–35.
ACOG Practice Bulletin No. 203: Chronic Hypertension in Pregnancy. Obstet Gynecol. 2019;133:e26–e50.
Nzelu D, Dumitrascu-Biris D, Kay P, Nicolaides KH, Kametas NA. Severe hypertension, preeclampsia and small for gestational age in women with chronic hypertension diagnosed before and during pregnancy. Pregnancy Hypertens. 2018;14:200–4.
Nzelu D, Dumitrascu-Biris D, Nicolaides KH, Kametas NA. Chronic hypertension: first-trimester blood pressure control and likelihood of severe hypertension, preeclampsia, and small for gestational age. Am J Obstet Gynecol. 2018;218:331–7.
Espeche WG, Salazar MR, Minetto J, Leiva SC, Cerri G, Balbín E, et al. Hypertension arising after 20 weeks of gestation: gestational hypertension or masked chronic hypertension? J Hum Hypertens. 2023;37:813–7.
Hurrell A, Webster L, Chappell LC, Shennan AH. The assessment of blood pressure in pregnant women: pitfalls and novel approaches. Am J Obstet Gynecol. 2022;226:S804–18.
Standard of Recommendation for Weight Gain during Pregnancy Period. Biomed Environ Sci. 2022;35:875–7.
Zhou BF. Predictive values of body mass index and waist circumference for risk factors of certain related diseases in Chinese adults-study on optimal cut-off points of body mass index and waist circumference in Chinese adults. Biomed Environ Sci. 2002;15:83–96.
ACOG Practice Bulletin No. 202: Gestational Hypertension and Preeclampsia. Obstet Gynecol. 2019;133:1. https://doi.org/10.1097/AOG.0000000000003018.
Poon LC, Shennan A, Hyett JA, Kapur A, Hadar E, Divakar H, et al. The International Federation of Gynecology and Obstetrics (FIGO) initiative on pre-eclampsia: A pragmatic guide for first-trimester screening and prevention. Int J Gynaecol Obstet. 2019;145 Suppl 1:1–33.
Panaitescu AM, Syngelaki A, Prodan N, Akolekar R, Nicolaides KH. Chronic hypertension and adverse pregnancy outcome: a cohort study. Ultrasound Obst Gynecol.: the official journal of the International Society of Ultrasound in Obstetrics and Gynecology. 2017;50:228–35.
Lin L, Huai J, Li B, Zhu Y, Juan J, Zhang M, et al. A randomized controlled trial of low-dose aspirin for the prevention of preeclampsia in women at high risk in China. Am J Obstet Gynecol. 2022;226:251.
Ankumah NA, Cantu J, Jauk V, Biggio J, Hauth J, Andrews W, et al. Risk of adverse pregnancy outcomes in women with mild chronic hypertension before 20 weeks of gestation. Obstet Gynecol. 2014;123:966–72.
ACOG Committee Opinion No. 743: Low-Dose Aspirin Use During Pregnancy. Obstet gynecol. 2018;132:e44–52.
Malha L, August P. Secondary Hypertension in Pregnancy. Curr Hypertens Rep. 2015;17:53.
Naruse K, Shigemi D, Hashiguchi M, Imamura M, Yasunaga H, Arai T. Placental abruption in each hypertensive disorders of pregnancy phenotype: a retrospective cohort study using a national inpatient database in Japan. Hypertens Res. 2021;44:232–8.
Hasegawa J, Toyokawa S, Ikenoue T, Asano Y, Satoh S, Ikeda T, et al. Relevant Obstetric Factors for Cerebral Palsy: From the Nationwide Obstetric Compensation System in Japan. PLOS ONE. 2016;11:e148122.
Ruiter L, Ravelli AC, de Graaf IM, Mol BW, Pajkrt E. Incidence and recurrence rate of placental abruption: a longitudinal linked national cohort study in the Netherlands. Am J Obstet Gynecol. 2015;213:571–3.
Guo Q, Feng P, Yu Q, Zhu W, Hu H, Chen X, et al. Associations of systolic blood pressure trajectories during pregnancy and risk of adverse perinatal outcomes. Hypertens Res. 2020;43:227–34.
Rezk M, Ellakwa H, Gamal A, Emara M. Maternal and fetal morbidity following discontinuation of antihypertensive drugs in mild to moderate chronic hypertension: A 4-year observational study. Pregnancy Hypertens. 2016;6:291.
Seely EW, Ecker J. Chronic hypertension in pregnancy. Circulation. 2014;129:1254–61.
Tsakiridis I, Giouleka S, Arvanitaki A, Mamopoulos A, Giannakoulas G, Papazisis G, et al. Chronic hypertension in pregnancy: synthesis of influential guidelines. J Perinat Med. 2021;49:859–72.
von Dadelszen P, Ornstein MP, Bull SB, Logan AG, Koren G, Magee LA. Fall in mean arterial pressure and fetal growth restriction in pregnancy hypertension: a meta-analysis. Lancet. 2000;355:87–92.
Whelton PK, Carey RM, Aronow WS, Casey DJ, Collins KJ, Dennison HC, et al. ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. J Am Coll Cardiol. 2017;2018:e127–248.
Hu J, Li Y, Zhang B, Zheng T, Li J, Peng Y, et al. Impact of the 2017 ACC/AHA Guideline for High Blood Pressure on Evaluating Gestational Hypertension-Associated Risks for Newborns and Mothers. Circ Res. 2019;125:184–94.
Garovic VD, Dechend R, Easterling T, Karumanchi SA, McMurtry BS, Magee LA, et al. Hypertension in Pregnancy: Diagnosis, Blood Pressure Goals, and Pharmacotherapy: A Scientific Statement From the American Heart Association. Hypertension. 2022;79:e21–41.
Hauspurg A, Sutton EF, Catov JM, Caritis SN. Aspirin Effect on Adverse Pregnancy Outcomes Associated With Stage 1 Hypertension in a High-Risk Cohort. Hypertension. 2018;72:202–7.
Ueda A, Hasegawa M, Matsumura N, Sato H, Kosaka K, Abiko K, et al. Lower systolic blood pressure levels in early pregnancy are associated with a decreased risk of early-onset superimposed preeclampsia in women with chronic hypertension: a multicenter retrospective study. Hypertens Res. 2022;45:135–45.
Magee LA, von Dadelszen P, Rey E, Ross S, Asztalos E, Murphy KE, et al. Less-tight versus tight control of hypertension in pregnancy. N Engl J Med. 2015;372:407–17.
Tita AT, Szychowski JM, Boggess K, Dugoff L, Sibai B, Lawrence K, et al. Treatment for Mild Chronic Hypertension during Pregnancy. N Engl J Med. 2022;386:1781–92.
Staff AC. The two-stage placental model of preeclampsia: An update. J Reprod Immunol. 2019;134-135:1–10.
Yanit KE, Snowden JM, Cheng YW, Caughey AB. The impact of chronic hypertension and pregestational diabetes on pregnancy outcomes. Am J Obstet Gynecol. 2012;207:331–3.
Reaven GM. Relationship between insulin resistance and hypertension. Diabetes Care. 1991;14:33–8.
Acknowledgements
I would particularly like to acknowledge my colleagues for their wonderful collaboration and support.
Funding
This work was supported by grants from the Guangdong Basic and Applied Basic Research Fund (Guangdong-Shenzhen Joint Fund) No.2021B1515120070.
Author information
Authors and Affiliations
Contributions
Put forward the original idea and design the protocol: QW Nie, F He. Extract clinical data: Qw Nie, Y Xue, Lj Pan, Md Jiang. Data analysis and interpretation: Qw Nie, Wz Liang, F He. Manuscript writing: Qw Nie, Weizhang Liang. Revise and polish the content: F He, Wz Liang.
Corresponding author
Ethics declarations
Competing interests
The authors declared no competing interests.
Ethical approval
The Institutional Ethics Committee of the Third Affiliated Hospital of Guangzhou Medical University approved the study protocol. According to national legislation and institutional guidelines, additional written informed consent from participants was waived for the retrospective nature of the study.
Additional information
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Nie, Q., Liang, W., Xue, Y. et al. Chronic hypertension diagnosed before or during pregnancy and its effects on pregnancy outcomes. J Hum Hypertens (2024). https://doi.org/10.1038/s41371-024-00944-z
Received:
Revised:
Accepted:
Published:
DOI: https://doi.org/10.1038/s41371-024-00944-z